Nonsquamous Non-small Cell Lung Cancer
3 competing products in clinical development for Nonsquamous Non-small Cell Lung Cancer.
Pipeline by Phase
Phase 33
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Patritumab Deruxtecan + Platinum-based chemotherapy | Daiichi Sankyo | Phase 3 | Active | 44 |
| Pembrolizumab + Carboplatin + Cisplatin + Pemetrexed + Lenvatinib + Placebo matching lenvatinib | Eisai | Phase 3 | Completed | 40 |
| Pembrolizumab + Carboplatin + Cisplatin + Pemetrexed + Lenvatinib + Placebo matching lenvatinib | Eisai | Phase 3 | Completed | 40 |